ストックスクリーナーアプリを入手
8.00
0.13%
0.010
アフターアワーズ：
8.00
Amicus Therapeutics Inc (FOLD) 最新ニュース
Zacks Research Issues Optimistic Estimate for FOLD Earnings - MarketBeat
Wellington Management Group LLP Buys 4,497,950 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Pictet Asset Management Holding SA Reduces Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Relative Strength Alert For Amicus Therapeutics - Nasdaq
Amicus Therapeutics (NASDAQ:FOLD) Reaches New 1-Year LowHere's What Happened - MarketBeat
Amicus Therapeutics stock hits 52-week low at $8.09 By Investing.com - Investing.com Australia
Amicus Therapeutics stock hits 52-week low at $8.09 - Investing.com India
How To Trade (FOLD) - news.stocktradersdaily.com
Amicus Therapeutics (NASDAQ:FOLD) Sets New 52-Week LowShould You Sell? - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Acquired by Fox Run Management L.L.C. - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Trading Down 2.5%Time to Sell? - MarketBeat
Is Amicus Therapeutics (NASDAQ:FOLD) A Risky Investment? - simplywall.st
Intech Investment Management LLC Has $1.18 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Pompe Disease Treatment Market Size in 7MM is expected to grow at - openPR.com
Amicus Therapeutics stock hits 52-week low at $8.54 By Investing.com - Investing.com UK
Semanteon Capital Management LP Purchases 43,288 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Pompe Disease Treatment Market reached US$ 1.39 billion in 2024 - openPR.com
Primecap Management Co. CA Sells 94,000 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Victory Capital Management Inc. Reduces Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance
Connor Clark & Lunn Investment Management Ltd. Has $2.85 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
How to Take Advantage of moves in (FOLD) - Stock Traders Daily
Pompe Disease Treatment Market Size, Potential Scope 2033 By Key - openPR.com
Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook - MSN
Great Lakes Advisors LLC Lowers Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Is Amicus Therapeutics Inc. (FOLD) the Best Nasdaq Stock Under $20 to Buy Now? - Insider Monkey
Amicus Therapeutics Is Very Attractive At Current Prices (Rating Upgrade) (NASDAQ:FOLD) - Seeking Alpha
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Inceptionr LLC - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Reaches New 52-Week LowTime to Sell? - MarketBeat
Pompe Disease Treatment Market Size in the 7MM is expected - openPR
Essex Investment Management Co. LLC Has $2.18 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (FOLD): Among the Stocks Under $10 With High Upside Potential - Insider Monkey
Amicus Therapeutics at Leerink Conference: Path to Profitability By Investing.com - Investing.com Canada
1.23%
1.63%
大文字化:
|
ボリューム (24 時間):